These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7587919)
1. Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients. Kayashima T; Yamaguchi K; Konno Y; Nanimatsu H; Aragaki S; Shichiri M Diabetes Res Clin Pract; 1995 May; 28(2):119-25. PubMed ID: 7587919 [TBL] [Abstract][Full Text] [Related]
2. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846 [TBL] [Abstract][Full Text] [Related]
3. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Chow CC; Tsang LW; Sorensen JP; Cockram CS Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472 [TBL] [Abstract][Full Text] [Related]
4. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
5. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467 [TBL] [Abstract][Full Text] [Related]
6. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. Weiss SR; Cheng SL; Kourides IA; Gelfand RA; Landschulz WH; Arch Intern Med; 2003 Oct; 163(19):2277-82. PubMed ID: 14581245 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Cusi K; Cunningham GR; Comstock JP Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511 [TBL] [Abstract][Full Text] [Related]
8. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM. Henricsson M; Janzon L; Groop L Diabetes Care; 1995 Dec; 18(12):1571-6. PubMed ID: 8722053 [TBL] [Abstract][Full Text] [Related]
9. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus. Rosenstock J; Meisel A; Raskin P Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402 [TBL] [Abstract][Full Text] [Related]
10. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345 [TBL] [Abstract][Full Text] [Related]
11. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Colwell JA Ann Intern Med; 1996 Jan; 124(1 Pt 2):131-5. PubMed ID: 8554205 [TBL] [Abstract][Full Text] [Related]
12. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Kishimoto M; Yamasaki Y; Kubota M; Arai K; Morishima T; Kawamori R; Kamada T Diabetes Care; 1995 Aug; 18(8):1156-9. PubMed ID: 7587851 [TBL] [Abstract][Full Text] [Related]
13. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918 [TBL] [Abstract][Full Text] [Related]
14. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Ryan EA; Imes S; Wallace C Diabetes Care; 2004 May; 27(5):1028-32. PubMed ID: 15111515 [TBL] [Abstract][Full Text] [Related]
15. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen MR J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709 [TBL] [Abstract][Full Text] [Related]
16. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins. Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551 [TBL] [Abstract][Full Text] [Related]
17. Clinical profile of lean NIDDM in South India. Mohan V; Vijayaprabha R; Rema M; Premalatha G; Poongothai S; Deepa R; Bhatia E; Mackay IR; Zimmet P Diabetes Res Clin Pract; 1997 Nov; 38(2):101-8. PubMed ID: 9483373 [TBL] [Abstract][Full Text] [Related]
18. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
19. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W; J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175 [TBL] [Abstract][Full Text] [Related]
20. Insulin regimens for the non-insulin dependent: impact on diurnal metabolic state and quality of life. Taylor R; Foster B; Kyne-Grzebalski D; Vanderpump M Diabet Med; 1994 Jul; 11(6):551-7. PubMed ID: 7955971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]